Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
NCT ID: NCT06553612
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
268 participants
INTERVENTIONAL
2024-06-07
2028-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
NCT05731661
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
NCT02323568
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NCT03418844
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
NCT05204342
Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation
NCT05763472
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Delivery of personalized post-cancer plan with multidisciplinary assessment of oncology support care needs in a day hospital
Multidisciplinary assessment
Delivery of a personalized post-cancer plan with multidisciplinary assessment of oncology support care needs in a day hospital
Control group
Delivery of a personalized post-cancer plan without a day hospital
Standard assesment
Delivery of a personalized post-cancer plan without a day hospital
Cohort
Follow-up as part of an observational cohort
Observational cohort
Patients with no cancer sequelae, no adverse effects and no need for oncological support care will not be randomized, but will be followed as part of an observational cohort
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multidisciplinary assessment
Delivery of a personalized post-cancer plan with multidisciplinary assessment of oncology support care needs in a day hospital
Standard assesment
Delivery of a personalized post-cancer plan without a day hospital
Observational cohort
Patients with no cancer sequelae, no adverse effects and no need for oncological support care will not be randomized, but will be followed as part of an observational cohort
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients in remission from first-line treatment of endometrial or ovarian/tumor/peritoneal cancer.
* Patient who has completed her initial treatment; patients on maintenance therapy are eligible.
* Fluency in French
* Patient with access to a telephone line
* Patient affiliated to a social security scheme
* Signature of informed consent prior to any specific study procedure
Exclusion Criteria
* Patient with locoregional or metastatic recurrence
* Patient deprived of liberty, under guardianship or curatorship
* Simultaneous participation in a therapeutic clinical trial
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Francois Baclesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU, Besançon
Besançon, , France
François Baclesse
Caen, , France
Centre Jean Perrin
Clermont-Ferrand, , France
Centre Léon Bérard
Lyon, , France
Hopital Diaconesses Croix Saint-Simon
Paris, , France
Hopital Europeen George Pompidou
Paris, , France
Hôpital COCHIN
Paris, , France
Institut Curie
Paris, , France
Hopital privé des Côtes d'Armor
Plérin, , France
Institut Curie, St Cloud
Saint-Cloud, , France
CHU, Saint Etienne
Saint-Etienne, , France
CHU
Strasbourg, , France
Gustave Roussy
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Laura MANSI, MD
Role: primary
Florence JOLY, Prof
Role: primary
Olivia LE SAUX, MD
Role: primary
Frederic SELLES, MD
Role: primary
Claire GERVAIS, MD
Role: primary
Anne Catherine PIKETTY, MD
Role: primary
Diana BELLO ROUFAI, MD
Role: primary
Jerome MARTIN-BABAU, MD
Role: primary
Diana BELLO ROUFAI, MD
Role: primary
Aurélie BENETON, MD
Role: primary
Virginie LEROY, MD
Role: primary
Patricia PAUTIER, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02554-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.